rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-7-16
|
pubmed:abstractText |
Creatine kinase MB (CK-MB), and cardiac troponin I (cTnI) are important biomarkers for the diagnosis and rule-out of acute myocardial infarction (AMI) of patients who presented to the emergency department (ED) with chest pain. With new rapid ED assessment protocols, there is increasing pressure to produce results with a short turnaround time (TAT), and point-of-care (POC) testing is one alternative for providing fast results.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0009-8981
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
346
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
211-9
|
pubmed:meshHeading |
pubmed-meshheading:15256323-Acute Disease,
pubmed-meshheading:15256323-Biological Markers,
pubmed-meshheading:15256323-Creatine Kinase,
pubmed-meshheading:15256323-Emergency Treatment,
pubmed-meshheading:15256323-Humans,
pubmed-meshheading:15256323-Myocardial Infarction,
pubmed-meshheading:15256323-Outcome Assessment (Health Care),
pubmed-meshheading:15256323-Point-of-Care Systems,
pubmed-meshheading:15256323-Reproducibility of Results,
pubmed-meshheading:15256323-Sensitivity and Specificity,
pubmed-meshheading:15256323-Troponin I
|
pubmed:year |
2004
|
pubmed:articleTitle |
Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, Hartford Hospital, 80 Seymour St., Hartford, CT 06102, USA. awu@harthosp.org
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|